Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : ADOT - BIOMODA: Profitable Technology with Purpose -- Ignore unavailable to you. Want to Upgrade?

To: normann who wrote (1640)	9/11/1998 10:39:00 AM
From: blessed	Read Replies (1) \| Respond to of 4650

Normann, According to the 10-SB, Adot owned 817K shares of Biomoda, with an option to buy an additional 249K over a 12 month period. Hope this helps. Blessed

To: normann who wrote (1640)	9/11/1998 10:48:00 AM
From: ksuave	Read Replies (1) \| Respond to of 4650

I know you've given some good advance info in the past, normann. From Brad's report a few weeks ago: "Mr. Ma'ayan said they have enough cash right now to complete this deal, but they might do another small private placement of about 100,000 to 200,000 shares of Biomoda (at about $1.50 to $2.00 a share) just to make sure thay are able to do everything without pinching." Who did you hear the $7-10 per share figure from?

To: normann who wrote (1640)	9/11/1998 2:09:00 PM
From: Brad	Read Replies (1) \| Respond to of 4650

Normann, I have heard the $10 to $20 range for the IPO when it ultimately happens. But between now and then, we are looking at... 1) possible small placement of 100 to 200 thousand shares of Biomoda at $1.50 to $2.00 per share. But as I understand, the window is about to close on that because the LungCheck results are due very shortly. Then they will be looking at the $3.50 to $4.00 range per share. 2) if Biomoda is not bought out (in whole or in part), then they want to do a larger private placement of 1 million shares at about $3.50 to $4.00 per share. 3) if Biomoda develops fully on their own (without a buyout), they would do an IPO of about 1 million shares in the $10 to $20 range. Again, that's just MY understanding from all my conversations with various sources. But the logic seems to make good sense to me.